-
COST OF AMPUTATION FOLLOWING LOWER EXTREMITY ENDOVASCULAR REVASCULARIZATION IN PERIPHERAL ARTERY DISEASE
Mar 18, 2026, 21:38 PM -
ASSOCIATION BETWEEN PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL AMONG INDIVIDUALS RECEIVING FIRST-LINE TREATMENT FOR BRCA WILD-TYPE ADVANCED EPITHELIAL OVARIAN CANCER: A PATIENT-LEVEL ANALYSIS OF POOLED HISTORICAL CLINICAL TRIALS
Mar 18, 2026, 21:38 PM -
REAL-WORLD TREATMENT PATTERNS AND TREATMENT INTENSIFICATION IN METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) BY DISEASE VOLUME AND PRESENTATION
Mar 18, 2026, 21:38 PM -
THE FUTURE OF EVIDENCE SYNTHESIS AND GENERATION IN HEOR: A SECURE FRAMEWORK FOR DOMAIN SPECIFIC ADAPTATION AND FINE-TUNING OF LARGE LANGUAGE MODELS
Mar 18, 2026, 21:38 PM -
EVOLUTION OF HOMOLOGOUS RECOMBINATION REPAIR (HRR) GENETIC TESTING BY RACE AMONG PATIENTS WITH METASTATIC PROSTATE CANCER (MPC) IN A LARGE COMMUNITY ONCOLOGY SETTING IN THE US, 2015-2024
Mar 18, 2026, 21:38 PM -
ONE BIG BEAUTIFUL ACT (OBBA) MEDICAID FUNDING CHANGES IMPACT ON MEDICAID VOLUMES IN CLAIMS DATA; A STUDY OF IMPACT FROM REENROLLMENT REQUIREMENTS OF 2024
Mar 18, 2026, 21:38 PM -
EXPANDING ACCESS TO LONG-ACTING REVERSIBLE CONTRACEPTIVES: A STATE-LEVEL BUDGET IMPACT MODEL OF SOUTH CAROLINA
Mar 18, 2026, 21:38 PM -
HEALTH OUTCOMES AND IMPLEMENTATION EFFECTIVENESS OF THE ANKYLOSING SPONDYLITIS RURAL HEALTH PROJECT IN CHINA: A PROSPECTIVE COHORT STUDY FROM HEALTH EQUITY PERSPECTIVE
Mar 18, 2026, 21:38 PM -
COMPARATIVE MEASUREMENT OF ESKETAMINE RESPONSE IN TREATMENT-RESISTANT DEPRESSION USING PHQ-9 AND DSM-5 CRITERIA
Mar 18, 2026, 21:38 PM -
VALIDATION OF A NEW CLINICAL OUTCOME ASSESSMENT: THE VACCINATION EXPERIENCE QUESTIONNAIRE (VEQ)
Mar 18, 2026, 21:38 PM -
BURDEN OF HYPERTENSION AMONG PATIENTS WITH TYPE 2 DIABETES MELLITUS IN INDIA: EVIDENCE FROM A SYSTEMATIC REVIEW, META-ANALYSIS, AND REAL-WORLD OBSERVATIONAL STUDY
Mar 18, 2026, 21:38 PM -
FRACTURE INCIDENCE AND ECONOMIC BURDEN OF FEMALE PATIENTS WITH OSTEOPOROSIS AT VERY HIGH RISK OF FRACTURE IN CHINA
Mar 18, 2026, 21:38 PM -
COMMON VS FREQUENT: ASSESSING VARIABLE DISEASE PRESENTATION IN IGAN AND C3G, THROUGH HOME-REPORTED OUTCOMES AND PATIENT-REPORTED ENDPOINTS ANALYSES
Mar 18, 2026, 21:38 PM -
DOES HEALTH EXPENDITURE BUILD TRUST? EVIDENCE FROM OECD COUNTRIES, 2010-2022
Mar 18, 2026, 21:38 PM -
REAL-WORLD (RW) TREATMENT PATTERNS AND OUTCOMES IN PATIENTS WITH =2 LINES OF THERAPY (LOTS) FOR RECURRENT OR PROGRESSIVE ENDOMETRIAL CANCER
Mar 18, 2026, 21:38 PM -
USING A DISCRETE CHOICE EXPERIMENT TO EXPLORE PERIOPERATIVE TREATMENT PREFERENCES IN GASTRIC AND GASTROESOPHAGEAL CANCER
Mar 18, 2026, 21:38 PM -
IDENTIFYING (DIS-)AGREEMENT BETWEEN MODELS FOR EVALUATION OF EFFECTIVENESS OF RISK MINIMIZATION MEASURES (RMMS)
Mar 18, 2026, 21:38 PM -
INTERPROVINCIAL DISPARITIES IN ACCESS TO DERMATOLOGY TREATMENTS IN CANADA
Mar 18, 2026, 21:38 PM -
ESTIMATING THE HUMANISTIC AND ECONOMIC BURDEN OF INFLAMMATORY BOWEL DISEASE IN ADULTS IN THE GULF REGION
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF ARTIFICIAL INTELLIGENCE (AI)-ASSISTED BRAIN MAGNETIC RESONANCE IMAGING (MRI) INTERPRETATION IN ADVANCED LUNG CANCERS
Mar 18, 2026, 21:38 PM
